Search clinical trials for: Thrombocythemia, Essential

Total 1539 results

University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder and other conditions
Theracos

Completed

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Essential Hypertension

United States
Mayo Clinic

Completed

Next-Generation Pre-Operative Targeting for Thalamic DBS in the Treatment of Tremor

Essential Tremor

United States
InSightec

Active, not recruiting

Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor (ET004)

Neurologic Manifestations | Tremor | Tremor, Essential

Korea, Republic of, Canada
St. Joseph's Hospital and Medical Center, Phoenix

Enrolling by invitation

Deep Brain Stimulation (DBS) Data Base Study

Parkinson's Disease | Essential Tremor

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Secondary...

United States
Oslo University Hospital
University of Oslo; Umeå University; University of Geneva, Switzerland

Active, not recruiting

Nutrition Therapy in the Immature Infant (ImNuT) (ImNuT)

Immature Infant | Essential Fatty Acid Deficiency

Norway
National Institute on Alcohol Abuse and Alcoholism...

Completed

Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body Composition

Obesity | Healthy Subjects | Weight Gain | Women

United States
Institut National de la Santé Et de la Recherche...

Completed

Cerebello-thalamo-cortical Coupling in Essential Tremor (CERESTIM)

Essential Tremor

France
Incyte Corporation

Completed

An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

MPN (Myeloproliferative Neoplasms)

Canada, United States, Australia
University Hospital, Bordeaux
APTES 100 rue boileau 69006 Lyon

Completed

Thalamic LFPs and VIM DBS in Essential Tremor: Correlation, Evolution, and Therapeutic Perspectives (VIM-CLT)

Essential Tremor

France
Roswell Park Cancer Institute

Completed

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Myelodysplastic/Myeloproliferative Diseases | Nonmalignant Neoplasm

United States
Coordinación de Investigación en Salud, Mexico
Fresenius Kabi

Completed

Supplemented Low Protein Diet and Progression of CKD

Stage 4 Chronic Kidney Disease

Mexico
Alexandria University

Completed

Is Preoperative Urodynamics Essential for Women With Pelvic Organ Prolapse (urodynaemics)

Urogenital Prolapse

Egypt
Cadent Therapeutics

Completed

A Clinical Study to Evaluate CAD-1883 in Essential Tremor

Essential Tremor

United States
University of Minho
Foundation for Science and Technology, Portugal

Completed

Women With Breast Cancer Undergoing Chemotherapy: Implications in Quality of Life

Breast Cancer Female

Portugal
The Hong Kong Polytechnic University

Unknown

Hypertension Treatment Adherence Improving Trial

Hypertension,Essential

China, Hong Kong
Shire

Completed

Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID® (EMIX)

Essential Thrombocythemia (ET)

Italy
Boryung Pharmaceutical Co., Ltd

Completed

BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination (FINAL)

Essential Hypertension

Korea, Republic of
Novartis Pharmaceuticals

Terminated

A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Primary Myelofibrosis | Post-Polycythemia Vera | Post-Essential Thrombocytopenia

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Active, not recruiting

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP)

Primary Hypertension

China
Menarini Group
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Hypertension

Poland, Germany, Israel, Romania, Italy, Denmark, Czechia, Croatia
Addpharma Inc.

Completed

Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

Hypertension,Essential

Korea, Republic of
Baxter Healthcare Corporation

Terminated

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion

Essential Fatty Acid Deficiency (EFAD)

United States
Yuhan Corporation

Completed

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

Essential Thrombocythemia

Korea, Republic of
DongGuk University

Completed

Diagnosis of Hypertension by Home Blood Pressure Monitoring

Hypertension,Essential | Ambulatory Blood Pressure | Home Blood Pressure

Korea, Republic of
University of Arkansas

Completed

Nutritional Therapy Interventions in Heart Failure

Heart Failure NYHA Class II

United States
Novartis Pharmaceuticals

Completed

A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension

Essential Hypertension

United States
The University of Texas Health Science Center,...
HCA Houston Healthcare Southeast Hospital

Completed

Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting

Postoperative Nausea and Vomiting (PONV)

United States
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Terminated

The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line

Essential Thrombocythemia

France
Shire

Completed

The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)

Essential Thrombocythaemia

Sweden, United Kingdom, Spain
Research and Practical Clinical Center for Diagnostics...

Completed

Possibilities of Perceiving Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From Essential Hypertension Through a Social Network (SocialCor)

Prevention, Arterial Hypertension

Russian Federation
Novartis Pharmaceuticals

Completed

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

Idiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera Myelofibrosis

United Kingdom, Ireland, Germany, Italy, France
University of Colorado, Denver

Completed

Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. (PHENO)

Parkinson Disease | Supranuclear Palsy, Progressive | Multiple System Atrophy | Corticobasal Degeneration | Essential Tremor

United States
Possible
Nyaya Health Nepal; Ministry of Health and Population, Nepal

Withdrawn

Integrated NCD Intervention in Rural Nepal

Hypertension | Diabetes Mellitus, Type 2 | Chronic Obstructive Pulmonary Disease | Noncommunicable Diseases

Nepal
John Mascarenhas
Massachusetts General Hospital; Montefiore Medical Center

Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Primary Myelofibrosis | Polycythemia Vera | Post-essential Thrombocythemia Myelofibrosis | Chronic Phase Myelofibrosis

United States
Shire

Completed

French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia (FOX)

Essential Thrombocythemia

France
Shire

Completed

Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

Thrombocythemia, Essential

Spain, United Kingdom, Greece, Denmark, Italy, France, Finland, Norway, Sweden, Germany, Cyprus, Ireland, Netherlands, Portugal
Shire

Completed

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

Essential Thrombocythemia (ET)

Japan
Shire

Completed

Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

Essential Thrombocythemia (ET)

Japan
Novartis

Completed

A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension

Essential Hypertension

Spain, United States, Belgium, Egypt, Germany, Poland, Slovakia, Turkey
Shire

Completed

A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

Thrombocythemia, Hemorrhagic

Bulgaria, France, Hungary, Poland, Portugal, Serbia
St. Justine's Hospital
Canadian Institutes of Health Research (CIHR); Laboratoire RIVA

Terminated

PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams (PROTECT)

COVID-19

Canada
The University of Western Australia

Completed

Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor

Parkinson's Disease | Tremor

Australia
University of Arkansas

Withdrawn

Essential Amino Acid Supplementation in Older Adult COVID-19 Patients

Covid19

United States
Essential Medical, Inc.

Completed

MANTA Registry for Vascular Large-bore Closure (MARVEL)

Femoral Arteriotomy Closure

Netherlands, Denmark, Finland, Switzerland, Canada
Baxalta now part of Shire
CTI BioPharma

Withdrawn

A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis

Primary Myelofibrosis
University of British Columbia

Completed

Deep Brain Stimulation for Voice Tremor: Left, Right, or Both Hemispheres? (EVT)

Laryngeal Diseases | Essential Tremor | Deep Brain Stimulation | Action Tremor | Essential Voice Tremor | Tremor, Nerve

Canada
Baylor College of Medicine
Pfizer

Completed

Pregabalin in the Treatment of Essential Tremor

Essential Tremor

United States
University Ghent

Completed

Effects of Flavanoids in Essential Hypertension, Type 2 Diabetes and Healthy Persons

Vascular Complications, Diabetic

Belgium

Search clinical trials for: Thrombocythemia, Essential

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations